A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Descripteurs (mots clés)
Ajouter le résultat dans votre panier Affiner la recherche
Etendre la recherche sur niveau(x) vers le bas
Diagnostic et traitement médical du syndrome de Morton / Henri-Olivier Marion-Audibert in Revue du podologue, 90 (Novembre-décembre 2019)
[article]
in Revue du podologue > 90 (Novembre-décembre 2019) . - p. 10-12
Titre : Diagnostic et traitement médical du syndrome de Morton Type de document : article de périodique Auteurs : Henri-Olivier Marion-Audibert Année de publication : 2019 Article en page(s) : p. 10-12 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Névrome de Morton
[Thésaurus HELB]:Paramédical:névrome de Morton /Diagnostic
[Thésaurus Mesh]Douleur
[Thésaurus Mesh]Métatarsalgie
[Thésaurus Mesh]ThérapeutiqueMots-clés : Signe de Mulder troisième espace intermétatarsien Résumé : Le syndrome de Morton est une pathologie fréquente, liée à une souffrance d’un nerf digital plantaire entre les têtes métatarsiennes des troisième et quatrième orteils. La lésion nerveuse est en rapport avec une fibrose périneuronale. Le diagnostic clinique est souvent suffisant, mais l’échographie ou l’imagerie par résonance magnétique sont utiles pour les présentations atypiques. Le traitement reste avant tout médical Note de contenu : Cet article fait partie du dossier "Le syndrome de Norton" Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité R Périodique Erasme - périodiques Périodiques Disponible Effects of 4% Ethanol Sclerosing Injection on Morton's Neuroma: A Histologic Study / Patrick Deheer in Journal of the American Podiatric Medical Association, vol. 110, 05 (Septembre-octobre 2020)
[article]
in Journal of the American Podiatric Medical Association > vol. 110, 05 (Septembre-octobre 2020)
Titre : Effects of 4% Ethanol Sclerosing Injection on Morton's Neuroma: A Histologic Study Type de document : article de périodique Auteurs : Patrick Deheer ; Rickinder S. Bains ; Faye-Rose Grebenyuk ; Shrunjay Patel ; Tea Nguyen Année de publication : 2020 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:INJECTION
[Thésaurus HELB]:Paramédical:Névrome de Morton
[Thésaurus Mesh]Histologie
[Thésaurus Mesh]Solutions sclérosantes
[Thésaurus Mesh]ThérapeutiqueMots-clés : éthanol sclérosant injection de corticostéroïde ablation nerf Résumé : ackground
Nonoperational treatments for Morton's neuroma remain controversial because it is believed that sclerosing injections do not change nerve fibers on a cellular level. Up to 80% success rates with 4% ethanol sclerosing have been documented, and the remainder required operational removal of the painful nerve. We sought to evaluate the histologic characteristics of Morton's neuromas treated with 4% ethanol sclerosing injection versus corticosteroid injection alone in patients who required removal of the nerve for pain relief.
Methods
A retrospective histologic review was performed of 23 consecutive patients who were treated with either sclerosing injection or nonsclerosing injection and underwent nerve removal between September 1, 2012, and February 28, 2015.
Results
Of 19 patients who met the inclusion criteria, eight received sclerosing injections and 11 received nonsclerosing injections. Intraneural fibrosis was more severe in the nonsclerosing injection group (P = .008).
Conclusion
Histologic changes are seen in Morton's neuroma with the use of 4% ethanol sclerosing injection, contrary to findings from previous studies.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Efficacy of a Single Corticosteroid Injection for Morton’s Neuroma in Adults A Systematic Review / Steven R. Edwards in Journal of the American Podiatric Medical Association, vol. 111, 04 (Juillet-aout 2021)
[article]
in Journal of the American Podiatric Medical Association > vol. 111, 04 (Juillet-aout 2021)
Titre : Efficacy of a Single Corticosteroid Injection for Morton’s Neuroma in Adults A Systematic Review Type de document : article de périodique Auteurs : Steven R. Edwards ; Susannah Fleming ; Karl B. Landorf Année de publication : 2021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Névrome de Morton
[Thésaurus Mesh]Hormones corticosurrénaliennes
[Thésaurus Mesh]ThérapeutiqueRésumé : Background: Morton’s neuroma is a common condition that routinely presents in podiatric practice. The aim of this study was to systematically synthesize the evidence relating to the effectiveness of a corticosteroid injection for Morton’s neuroma. Methods: Studies with a publication date of 1960 or later were eligible, and searches were performed within the Turning Research Into Practice database; the Cochrane Central Register of Controlled Trials; the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register; MEDLINE (Ovid); PubMed; Embase; Cumulative Index to Nursing and Allied Health Literature; and the gray literature. Study selection criteria included randomized and nonrandomized controlled trials where a single corticosteroid injection for Morton’s neuroma pain was investigated. The primary outcome was Morton’s neuroma pain as measured by any standard validated pain scale. Results: Ten studies involving 695 participants were included. The quality of the studies was considered low and subject to bias. Of the included studies, five compared corticosteroid injection to usual care, one compared corticosteroid injection to local anesthetic alone, one compared ultrasound-guided to non–ultrasound-guided injections, three compared corticosteroid injections to surgery, one compared small to large neuromas, six assessed patient satisfaction, four measured adverse events, one studied return to work, and one examined failure of the corticosteroid injection to improve pain. Overall, these studies identified a moderate short- to medium-term benefit of corticosteroid injections on the primary outcome of pain and a low adverse event rate. Conclusions: A single corticosteroid injection appears to have a beneficial short- to medium-term effect on Morton’s neuroma pain. It appears superior to usual care, but its superiority to local anaesthetic alone is questionable, and it is inferior to surgical excision. A very low adverse event rate was noted throughout the studies, indicating the intervention is safe when used for Morton’s neuroma. However, the quality of the evidence is low, and these findings may change with further research. Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Extracorporeal Shockwave Therapy for Foot and Ankle Disorders A Systematic Review and Meta-Analysis / Tengku Nazim B. Tengku Yusof in Journal of the American Podiatric Medical Association, vol. 112, 03 (Mai 2022)
[article]
in Journal of the American Podiatric Medical Association > vol. 112, 03 (Mai 2022)
Titre : Extracorporeal Shockwave Therapy for Foot and Ankle Disorders A Systematic Review and Meta-Analysis Type de document : article de périodique Auteurs : Tengku Nazim B. Tengku Yusof ; Dexter Seow ; Khushdeep S. Vig Année de publication : 2022 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Névrome de Morton
[Thésaurus Mesh]Épine calcanéenne
[Thésaurus Mesh]Fasciite plantaire
[Thésaurus Mesh]Méta-analyse comme sujet
[Thésaurus Mesh]Revue de la littérature
[Thésaurus Mesh]Tendinopathie
[Thésaurus Mesh]Traumatismes de la cheville
[Thésaurus Mesh]Traumatismes du piedMots-clés : Traitement par ondes de choc extracorporelles Résumé : A Systematic Review and Meta-AnalysisBackground: Extracorporeal shockwave therapy (ESWT) was first introduced into clinical practice in 1982 and has been a beneficial inclusion to the noninvasive treatment option of numerous orthopaedic pathologies. However, clinical evidence of the use of ESWT for various foot and ankle disorders has been limited with a consensus on its efficacy yet available. Therefore, the purpose of this study is to systematically review the literature, to provide a critical evaluation and meta-analysis for the use of ESWT in foot and ankle disorders. Methods: The PubMed and Embase databases were systematically reviewed and clinical studies that reported ESWT use for various foot and ankle disorders included. Results: A total of 24 clinical studies that included 12 randomized controlled trials and 12 case series were identified. Analysis of the evidence has indicated that ESWT can help manage plantar fasciitis, calcaneal spur, Achilles tendinopathy and Morton’s neuroma. Meta-analysis of the change in pre- to post-VAS overall scores for plantar fasciitis significantly favored ESWT compared to placebo/conservative treatment with a MD -3.10 (95% CI, -4.36 to -1.83; I 2 = 68%; P , 0.00001). Conclusions: The current evidence has suggested that ESWT can provide symptomatic benefit to plantar fasciitis treatment, with minimal and unremarkable side effects. Overall, ESWT has been demonstrated to be a safe treatment option with a favorable complication profile. Further well-designed studies of ESWT for the treatment of calcaneal spurs, Achilles tendinopathy and Morton’s neuroma are warranted to more soundly and safely support its current use. Future studies are suggested to investigate the optimization of ESWT treatment protocols. Note de contenu :
Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Extracorporeal shockwave therapy in patients with Morton's Neuroma : a randomized, placebo-controlled trial / Hyun Seok in Journal of the American Podiatric Medical Association, vol.106, 2 (Mars-avril 2016)
[article]
in Journal of the American Podiatric Medical Association > vol.106, 2 (Mars-avril 2016) . - 93-99
Titre : Extracorporeal shockwave therapy in patients with Morton's Neuroma : a randomized, placebo-controlled trial Type de document : article de périodique Auteurs : Hyun Seok, Auteur ; Sang-Hyun Kim, Auteur ; Seo-Yeol Lee, Auteur Année de publication : 2016 Article en page(s) : 93-99 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Névrome de Morton
[Thésaurus Mesh]Douleur
[Thésaurus Mesh]Pied
[Thésaurus Mesh]Thérapie à ondes courtesMots-clés : ESWT Extracorporeal schokwave therapy Résumé : Background: The aim of this study was to evaluate the efficacy of extracorporeal shockwave therapy (ESWT) for the treatment of Morton's neuroma by measuring changes in patient pain, function, and neuroma size.
Methods: Patients with Morton's neuroma were randomly assigned to either the ESWT group or the sham stimulation group. Outcome measures, including visual analog scale (VAS) and American Orthopaedic Foot and Ankle Society lesser toes (AOFAS) scores, were assessed at baseline and 1 and 4 weeks after treatment. The Johnson satisfaction test was also performed 1 and 4 weeks after treatment. The neuroma diameter was measured using ultrasonography at baseline and 4 weeks after treatment.
Results: Patients receiving ESWT exhibited significantly decreased VAS scores 1 and 4 weeks after treatment relative to baseline, and AOFAS scores were significantly improved 4 weeks after treatment relative to baseline. In the sham stimulation group, VAS and AOFAS scores showed no significant changes at any time after treatment. Neither group showed significant changes in Johnson satisfaction test results or neuroma diameter.
Conclusions: These results suggest that ESWT may reduce pain in patients with Morton's neuroma.Note de contenu : Article original Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité J Périodique Erasme - périodiques Périodiques Disponible Giant Morton’s neuroma (A) / S.E. Clubb in The Foot, vol.15, 3 (Septembre 2005)
PermalinkNeurectomy for bilateral morton’s neuroma : a case report of a male patient / Terufumi Shibata in Journal of the American Podiatric Medical Association, vol.106, 3 (Mai-juin 2016)
PermalinkPrise en charge chirurgicale du névrome de Morton / Jean Langlois in Revue du podologue, 90 (Novembre-décembre 2019)
PermalinkUne prise en charge podologique d’un névrome de Morton / Nicolas Reymond in Revue du podologue, 90 (Novembre-décembre 2019)
PermalinkSclerosing alcohol injections for the management of intermetatarsal neuromas: a systematic review / Derek Santos in The Foot, 35 (Juin 2018)
PermalinkSex Correlation to the Prevalence of Pedal Neuromas in Various Interspaces: A Retrospective Study / Patrick Deheer in Journal of the American Podiatric Medical Association, vol. 110, 05 (Septembre-octobre 2020)
PermalinkSyndromes canalaires : aspect chirurgical / Cyrille Cazeau in Revue du podologue, 92 (Mars 2020)
PermalinkTailoring orthotic modifications for hallux valgus, flexible hammertoe deformities and morton’s neuroma in Podiatry today, vol. 31, 4 (Avril 2018)
PermalinkToutes les métatarsalgies plantaires ne sont pas des syndromes de Morton / Christophe Piat in Revue du podologue, 98 (Mars 2021)
PermalinkLe trajet d’un névrome de Morton / Robert Wonink in Le pied médical, 3 (Septembre 2012)
PermalinkUltrasound-Guided Decompression of the Intermetatarsal Nerve for Morton's Neuroma: A Novel Closed Surgical Technique / Marcos Alvarez Garcia in Journal of the American Podiatric Medical Association, vol. 110, 06 (Novembre-décembre 2020)
Permalink